Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,541 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection - Increasing Community Access to Testing Program, United States, September-November 2022.
Link-Gelles R, Ciesla AA, Fleming-Dutra KE, Smith ZR, Britton A, Wiegand RE, Miller JD, Accorsi EK, Schrag SJ, Verani JR, Shang N, Derado G, Pilishvili T. Link-Gelles R, et al. Among authors: miller jd. MMWR Morb Mortal Wkly Rep. 2022 Dec 2;71(48):1526-1530. doi: 10.15585/mmwr.mm7148e1. MMWR Morb Mortal Wkly Rep. 2022. PMID: 36454688 Free PMC article.
Spike Gene Target Amplification in a Diagnostic Assay as a Marker for Public Health Monitoring of Emerging SARS-CoV-2 Variants - United States, November 2021-January 2023.
Scobie HM, Ali AR, Shirk P, Smith ZR, Paul P, Paden CR, Hassell N, Zheng XY, Lambrou AS, Kondor R, MacCannell D, Thornburg NJ, Miller J, Wentworth D, Silk BJ. Scobie HM, et al. MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):125-127. doi: 10.15585/mmwr.mm7205e2. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36730050 Free PMC article.
Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5- and XBB/XBB.1.5-Related Sublineages Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, December 2022-January 2023.
Link-Gelles R, Ciesla AA, Roper LE, Scobie HM, Ali AR, Miller JD, Wiegand RE, Accorsi EK, Verani JR, Shang N, Derado G, Britton A, Smith ZR, Fleming-Dutra KE. Link-Gelles R, et al. Among authors: miller jd. MMWR Morb Mortal Wkly Rep. 2023 Feb 3;72(5):119-124. doi: 10.15585/mmwr.mm7205e1. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36730051 Free PMC article.
Preliminary Estimates of Effectiveness of Monovalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection Among Children Aged 3-5 Years - Increasing Community Access to Testing Program, United States, July 2022-February 2023.
Fleming-Dutra KE, Ciesla AA, Roper LE, Smith ZR, Miller JD, Accorsi EK, Verani JR, Shang N, Derado G, Wiegand RE, Pilishvili T, Britton A, Link-Gelles R. Fleming-Dutra KE, et al. Among authors: miller jd. MMWR Morb Mortal Wkly Rep. 2023 Feb 17;72(7):177-182. doi: 10.15585/mmwr.mm7207a3. MMWR Morb Mortal Wkly Rep. 2023. PMID: 36795625 Free PMC article.
Effectiveness of Booster Doses of Monovalent mRNA COVID-19 Vaccine Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children, Adolescents, and Adults During Omicron Subvariant BA.2/BA.2.12.1 and BA.4/BA.5 Predominant Periods.
Ciesla AA, Wiegand RE, Smith ZR, Britton A, Fleming-Dutra KE, Miller J, Accorsi EK, Verani JR, Shang N, Derado G, Pilishvili T, Link-Gelles R. Ciesla AA, et al. Open Forum Infect Dis. 2023 Apr 13;10(5):ofad187. doi: 10.1093/ofid/ofad187. eCollection 2023 May. Open Forum Infect Dis. 2023. PMID: 37213428 Free PMC article.
Early Estimates of Updated 2023-2024 (Monovalent XBB.1.5) COVID-19 Vaccine Effectiveness Against Symptomatic SARS-CoV-2 Infection Attributable to Co-Circulating Omicron Variants Among Immunocompetent Adults - Increasing Community Access to Testing Program, United States, September 2023-January 2024.
Link-Gelles R, Ciesla AA, Mak J, Miller JD, Silk BJ, Lambrou AS, Paden CR, Shirk P, Britton A, Smith ZR, Fleming-Dutra KE. Link-Gelles R, et al. Among authors: miller jd. MMWR Morb Mortal Wkly Rep. 2024 Feb 1;73(4):77-83. doi: 10.15585/mmwr.mm7304a2. MMWR Morb Mortal Wkly Rep. 2024. PMID: 38300853 Free PMC article.
Nature and human well-being: The olfactory pathway.
Bratman GN, Bembibre C, Daily GC, Doty RL, Hummel T, Jacobs LF, Kahn PH Jr, Lashus C, Majid A, Miller JD, Oleszkiewicz A, Olvera-Alvarez H, Parma V, Riederer AM, Sieber NL, Williams J, Xiao J, Yu CP, Spengler JD. Bratman GN, et al. Among authors: miller jd. Sci Adv. 2024 May 17;10(20):eadn3028. doi: 10.1126/sciadv.adn3028. Epub 2024 May 15. Sci Adv. 2024. PMID: 38748806 Free article. Review.
Variations in household water affordability and water insecurity: An intersectional perspective from 18 low- and middle-income countries.
Shah SH, Harris LM, Menghwani V, Stoler J, Brewis A, Miller JD, Workman CL, Adams EA, Pearson AL, Hagaman A, Wutich A, Young SL; Household Water Insecurity Experiences Research Coordination Network (HWISE RCN). Shah SH, et al. Among authors: miller jd. Environ Plan F Philos Theory Models Method Pract. 2023 Sep;2(3):369-398. doi: 10.1177/26349825231156900. Epub 2023 Mar 15. Environ Plan F Philos Theory Models Method Pract. 2023. PMID: 38707600 Free PMC article.
1,541 results